BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16372335)

  • 1. Characterization of an antibody that can detect the Kai1/CD82 murine metastasis suppressor.
    Custer MC; Risinger JI; Hoover S; Simpson RM; Patterson T; Barrett JC
    Prostate; 2006 May; 66(6):567-77. PubMed ID: 16372335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The palmitoylation of metastasis suppressor KAI1/CD82 is important for its motility- and invasiveness-inhibitory activity.
    Zhou B; Liu L; Reddivari M; Zhang XA
    Cancer Res; 2004 Oct; 64(20):7455-63. PubMed ID: 15492270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EWI2/PGRL associates with the metastasis suppressor KAI1/CD82 and inhibits the migration of prostate cancer cells.
    Zhang XA; Lane WS; Charrin S; Rubinstein E; Liu L
    Cancer Res; 2003 May; 63(10):2665-74. PubMed ID: 12750295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of KAI1 on tumor cells with DARC on vascular endothelium leads to metastasis suppression.
    Bandyopadhyay S; Zhan R; Chaudhuri A; Watabe M; Pai SK; Hirota S; Hosobe S; Tsukada T; Miura K; Takano Y; Saito K; Pauza ME; Hayashi S; Wang Y; Mohinta S; Mashimo T; Iiizumi M; Furuta E; Watabe K
    Nat Med; 2006 Aug; 12(8):933-8. PubMed ID: 16862154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased expression of KAI1/CD82 metastasis suppressor gene is associated with loss of heterozygosity in melanoma cell lines.
    Kim YI; Shin MK; Lee JW; Chung JH; Lee MH
    Oncol Rep; 2009 Jan; 21(1):159-64. PubMed ID: 19082457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KAI1/CD82, a tumor metastasis suppressor.
    Liu WM; Zhang XA
    Cancer Lett; 2006 Aug; 240(2):183-94. PubMed ID: 16260083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastasis-suppressor KAI1/CD82 induces homotypic aggregation of human prostate cancer cells through Src-dependent pathway.
    Jee B; Jin K; Hahn JH; Song HG; Lee H
    Exp Mol Med; 2003 Feb; 35(1):30-7. PubMed ID: 12642901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression Levels of Tetraspanin KAI1/CD82 in Breast Cancers in North Indian Females.
    Singh R; Bhatt ML; Singh SP; Kumar V; Goel MM; Mishra DP; Srivastava K; Kumar R
    Asian Pac J Cancer Prev; 2016; 17(7):3431-6. PubMed ID: 27509988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of tumor metastasis suppressor gene KAI1/CD82 in human cancer cell lines with different metastasis potential].
    Li S; Fang W; Zhong H
    Zhonghua Yi Xue Za Zhi; 1999 Sep; 79(9):708-10. PubMed ID: 11715465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KAI1/CD82 is a novel target of estrogen receptor-mediated gene repression and downregulated in primary human breast cancer.
    Christgen M; Bruchhardt H; Ballmaier M; Krech T; Länger F; Kreipe H; Lehmann U
    Int J Cancer; 2008 Nov; 123(10):2239-46. PubMed ID: 18712725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer.
    Adachi M; Taki T; Ieki Y; Huang CL; Higashiyama M; Miyake M
    Cancer Res; 1996 Apr; 56(8):1751-5. PubMed ID: 8620488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastasis suppressor KAI1/CD82 attenuates the matrix adhesion of human prostate cancer cells by suppressing fibronectin expression and β1 integrin activation.
    Lee HA; Park I; Byun HJ; Jeoung D; Kim YM; Lee H
    Cell Physiol Biochem; 2011; 27(5):575-86. PubMed ID: 21691075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of tumor suppressor gene KAI1 on the biological behaviors of human colorectal carcinoma].
    Liu L; Li ZG; Yang GZ; Ding YQ
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Jun; 23(6):587-90, 594. PubMed ID: 12810384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of decreased expression of KAI1 metastasis suppressor in human oral carcinogenesis.
    Uzawa K; Ono K; Suzuki H; Tanaka C; Yakushiji T; Yamamoto N; Yokoe H; Tanzawa H
    Clin Cancer Res; 2002 Mar; 8(3):828-35. PubMed ID: 11895916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma.
    Uchida S; Shimada Y; Watanabe G; Li ZG; Hong T; Miyake M; Imamura M
    Br J Cancer; 1999 Mar; 79(7-8):1168-73. PubMed ID: 10098753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transduction of KAI1/CD82 cDNA promotes hematogenous spread of human lung-cancer cells in natural killer cell-depleted SCID mice.
    Shinohara T; Nishimura N; Hanibuchi M; Nokihara H; Miki T; Hamada H; Sone S
    Int J Cancer; 2001 Oct; 94(1):16-23. PubMed ID: 11668473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of KAI1/CD82 expression in bone and soft tissue tumors is not associated with lung metastasis.
    Arihiro K; Inai K
    Pathol Res Pract; 2001; 197(9):627-33. PubMed ID: 11569927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of tumor metastasis suppressor gene KAI1 in digestive tract carcinomas and cancer cells.
    Wu Q; Ji Y; Zhang MQ; Chen YQ; Chen F; Shi DL; Zheng ZH; Huang YJ; Su WJ
    Cell Tissue Res; 2003 Nov; 314(2):237-49. PubMed ID: 12955496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transmembrane interactions are needed for KAI1/CD82-mediated suppression of cancer invasion and metastasis.
    Bari R; Zhang YH; Zhang F; Wang NX; Stipp CS; Zheng JJ; Zhang XA
    Am J Pathol; 2009 Feb; 174(2):647-60. PubMed ID: 19116362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of KAI1/CD82 and MRP-1/CD9 in transitional cell carcinoma of bladder.
    Ai X; Zhang X; Wu Z; Ma X; Ju Z; Wang B; Shi T
    J Huazhong Univ Sci Technolog Med Sci; 2007 Feb; 27(1):79-82. PubMed ID: 17393117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.